http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Mississauga, Ontario, Canada - November 11, 2009 - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to... http://pharmalicensing.com/redirs/news_rss//public/news/view/499711/0/2/nuvo-research-provides-wf10-licensing-and-development-update http://pharmalicensing.com/redirs/news_rss//public/news/view/499711/0/2/nuvo-research-provides-wf10-licensing-and-development-update Birmingham, United Kingdom, November 11, 2009 - Finnish molecular diagnostics company Mobidiag releases rapid microarray solution for identifying bacteria responsible for bone and joint infections... http://pharmalicensing.com/redirs/news_rss//public/news/view/499724/0/2/mobidiag-launches-rapid-dna-microarray-technology-for-diagnostics-of-bone-and-joint-infections http://pharmalicensing.com/redirs/news_rss//public/news/view/499724/0/2/mobidiag-launches-rapid-dna-microarray-technology-for-diagnostics-of-bone-and-joint-infections Rehovot (Israel), November 3, 2009 -- Foamix Ltd, a global leader in the development of dermatological foam medications today announced that the company has extended its agreement with Galderma to... http://pharmalicensing.com/redirs/news_rss//public/news/view/498856/0/2/foamix-extends-collaboration-with-galderma http://pharmalicensing.com/redirs/news_rss//public/news/view/498856/0/2/foamix-extends-collaboration-with-galderma CHICAGO, Nov. 2, 2009 - Xoft, Inc., developer of the Axxent http://pharmalicensing.com/redirs/news_rss//public/news/view/499591/0/2/xoft-showcases-multi-disciplinary-electronic-brachytherapy-cancer-treatment-platform-at-astro http://pharmalicensing.com/redirs/news_rss//public/news/view/499591/0/2/xoft-showcases-multi-disciplinary-electronic-brachytherapy-cancer-treatment-platform-at-astro